This is a routine credit facility refinancing with no material change to Cardinal Health's financial position or outlook. Monitor the next quarterly filing for any update on leverage or use of the facility, but no immediate trading action is warranted.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 11 $240.26entry
- T+1 · 3mo ago −2.54%α −2.79% · $234.16
- T+5 · 3mo ago −2.20%α −1.79% · $234.98
- T+20 · 2mo ago −0.14%α +0.92% · $239.92
- T+60 · 13d ago +9.02%α +9.51% · $261.93
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility, replacing its existing $2.0 billion five-year facility, $1.0 billion 364-day facility, and $1.0 billion receivables sale program. The new facility matures on August 7, 2031, with an option to extend by up to two years, and carries a maximum consolidated net leverage ratio of 4.00x. This is a routine refinancing that consolidates and extends the company's credit lines at a larger total capacity, with no financial data indicating distress or material change in operations.
Key Financial Metrics
Key Facts
- Cardinal Health entered into a new $4.0 billion unsecured revolving credit facility on August 7, 2026.
- The facility matures on August 7, 2031, with an option to extend by up to two years.
- The new facility replaces the existing $2.0 billion five-year facility, $1.0 billion 364-day facility, and $1.0 billion receivables sale program.
- The financial covenant requires a Consolidated Net Leverage Ratio of no greater than 4.00 to 1.00.
- No penalties were incurred from the termination of the prior facilities.
Financial Impact
Routine refinancing of $4.0 billion in aggregate credit facilities; no new debt drawn or financial impact disclosed.
Risk Factors
- No material risks identified from this routine refinancing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000721371-26-000036 |
| Document: cah-20260807.htm | 0000721371-26-000036 |
| Document: 0000721371-26-000036-index-headers.html | 0000721371-26-000036 |
| Document: 0000721371-26-000036-index.html | 0000721371-26-000036 |
| Document: 0000721371-26-000036.txt | 0000721371-26-000036 |
Track record
17 reports on CAH
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 3 Neutral 2/10 Entry $283.50 Now $283.85 +0.12% settles Nov 24
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $283.35 Now $283.85 −0.18% settles Nov 23
- Nov 11, 20265d ago Press Release Neutral 2/10 Entry $278.14 Now $283.85 +2.05% settles Nov 19
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $267.82 to $278.14 Now $283.85 +5.99% ▲ +3.85% +0.56% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $251.09 to $267.82 Now $283.85 +13.05% ▲ +6.66% +11.39% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $244.76 to $261.93 Now $283.85 +15.97% ▲ +7.01% +7.73% vs SPY
- Oct 27, 202621d ago GOVT-CONTRACT Neutral 4/10 Entry $244.76 to $261.93 Now $283.85 +15.97% ▲ +7.01% +7.73% vs SPY
- Oct 1, 20266w ago 8-K Neutral 5/10 Entry $230.09 to $238.96 Now $283.85 +23.36% ▲ +3.85% +2.55% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $230.09 to $238.96 Now $283.85 +23.36% ▲ +3.85% +2.55% vs SPY
- Aug 20, 202612w ago Insider Cluster Neutral 4/10 Entry $228.46 to $235.13 Now $283.85 +24.24% ▲ +2.92% +1.80% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers